ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer.

Subrata Manna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.